FIELD: medicine, pharmacy. SUBSTANCE: invention relates to medicinal forms containing interferon preparations. Alpha-2 interferon-base ointment has additionally vitamin C (ascorbic acid), vitamin E (tocopherol) and an ointment base taken at the definite amount. Invention ensures to decrease interferon concentration. EFFECT: improved quality of preparation, retained therapeutic activity, broadened indications for the using. 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT POSSESSING IMMUNOMODULATORY AND ANTIVIRAL ACTIVITY | 2015 |
|
RU2592201C1 |
| RECTAL SUPPOSITORIES AND DEVICE FOR INTRODUCTION THEREOF | 1991 |
|
RU2024253C1 |
| MEDICINE WITH IMMUNE MODIFYING, ANTIVIRUS, ANTIBACTERIAL ANTIOXIDISING, MEMBRANE STABILISING, CARTILAGE AND CONNECTIVE TISSUE GROWTH STIMULATING EFFECT | 2007 |
|
RU2349339C1 |
| CURATIVE AGENT | 2005 |
|
RU2283133C1 |
| IMMUNOCORRECTIVE AGENT FOR TREATING DISEASES OF VIRAL AETIOLOGY | 2007 |
|
RU2411039C2 |
| METHOD OF TREATMENT OF RECURRING HERPES SIMPLEX | 0 |
|
SU1530189A1 |
| HYPOALLERGENIC MEDICINAL AGENT APPLIED FOR TREATMENT OF INFECTION-INFLAMMATORY DISEASES OF DIFFERENT AETIOLOGY | 2007 |
|
RU2326688C1 |
| MEDICINAL GEL | 2000 |
|
RU2184564C2 |
| IMMUNOMODULATING, ANTIVIRAL, ANTIBACTERIAL, ANTIOXIDATING, MEMBRANE STABILISING, ANTI-INFLAMMATORY, ANTITOXIC MEDICINAL AGENT FOR INFLAMMATORY-INFECTIOUS DISEASES | 2007 |
|
RU2327486C1 |
| ANALGETIC AND ANTI-ITCHING AGENT | 1997 |
|
RU2147440C1 |
